oseltamivir
Commercial- Indications
- Influenza
Company intelligence / Profile preview
HEC Pharm is a leading Chinese pharmaceutical company specializing in the manufacture of APIs and finished dosage forms. It became the largest manufacturer of oseltamivir in China after licensing from Roche in 2006 and played a key role during the H1N1 crisis by supplying nearly all national demand. The company also claims to be the world’s largest producer of macrolide antibiotics APIs and supplies global clients such as Pfizer and Abbott Laboratories. Its products are FDA & EDQM approved.
1 more asset in the full pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HEC Pharm.